Ambulatory teclistamab administration in patients with relapsed/refractory multiple myeloma

被引：0
|
作者：
Tabbara, Nadeem
Singel, Michael
Allen, Natalie
Mooney, Kathy
Shedeck, Audra
Zukas, Amber
Campion, Kate
Sollenberger, Callan
Gocke, Christian Burris
Ali, Syed Abbas
Huff, Carol Ann
Imus, Philip H.
Waheed, Sarah
机构：
[1] Johns Hopkins Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD USA
[2] Johns Hopkins Univ, Baltimore, MD USA
[3] Johns Hopkins Sidney Kimmel Comprehens Canc Ctr, Washington, DC USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
11146
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Pharmacological dose ascorbic acid administration in relapsed refractory multiple myeloma patients
    Bolaman, Ali Zahit
    Turgutkaya, Atakan
    Kucukdiler, Hilal Eroglu
    Selim, Cem
    Yavasoglu, Irfan
    LEUKEMIA RESEARCH REPORTS, 2021, 16
  • [22] Teclistamab for Relapsed/Refractory Multiple Myeloma: Real-World Experience in an Early Access Program
    Uttervall, Katarina
    Nahi, Hareth
    Kashif, Muhammad
    Lemonakis, Konstantinos
    Rosengren, Sara
    Brolin, Janaki
    Lund, Johan
    Hansson, Markus
    BLOOD, 2022, 140 : 12605 - 12606
  • [23] Real-World Experience with Teclistamab for Relapsed/ Refractory Multiple Myeloma from the US Myeloma Immunotherapy Consortium
    Razzo, Beatrice
    Grajales-Cruz, Ariel
    Atrash, Shebli
    Ferreri, Christopher
    Goyal, Anmol
    Pasvolsky, Oren
    Banerjee, Rahul
    Julian, Kelley
    Forsberg, Peter
    Herr, Megan
    Lin, Yi
    Susanibar-Adaniya, Sandra
    Khouri, Jack
    Vazquez-Martinez, Mariola
    Lee, Hans
    Portuguese, Andrew
    Sborov, Douglas W.
    Dima, Danai
    Davis, James
    Kaur, Gurbakhash
    Shune, Leyla
    Hansen, Doris
    Sidana, Surbhi
    Garfall, Alfred
    Richard, Shambavi
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S82 - S83
  • [24] Efficacy and safety of teclistamab in relapsed or refractory multiple myeloma: a systematic review and meta-analysis
    Qureshi, Zaheer
    Jamil, Abdur
    Altaf, Faryal
    Siddique, Rimsha
    Ahmed, Faizan
    ANNALS OF HEMATOLOGY, 2024, : 4901 - 4912
  • [25] Teclistamab in relapsed refractory multiple myeloma: multi-institutional real-world study
    Meera Mohan
    Jorge Monge
    Nishi Shah
    Danny Luan
    Mark Forsberg
    Vineel Bhatlapenumarthi
    Metodi Balev
    Anannya Patwari
    Heloise Cheruvalath
    Divaya Bhutani
    Sharmilan Thanendrarajan
    Binod Dhakal
    Maurizio Zangari
    Samer Al-Hadidi
    Dennis Cooper
    Suzanne Lentzsch
    Frits van Rhee
    Anita D’Souza
    Aniko Szabo
    Carolina Schinke
    Rajshekhar Chakraborty
    Blood Cancer Journal, 14
  • [26] Efficacy and Safety of Teclistamab in Relapsed or Refractory Multiple Myeloma: A Systematic Review and Meta-Analysis
    Qureshi, Zaheer
    Jamil, Abdur
    Altaf, Faryal
    Siddique, Rimsha
    Faisal, Muhammad Salman
    Gupta, Sorab
    Berard, Paul Edward
    BLOOD, 2024, 144 : 7010 - 7011
  • [27] BENDAMUSTINE IN PATIENTS WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA
    Michael, M.
    Bruns, I.
    Boelke, E.
    Zohren, F.
    Czibere, A.
    Safaian, N. N.
    Ncumann, F.
    Haas, R.
    Kobbe, G.
    Fenk, R.
    EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2010, 15 (01) : 13 - 19
  • [28] Teclistamab in Relapsed Refractory Multiple Myeloma: Multi-Institutional Real-World Study
    Mohan, Meera
    Shah, Nishi
    Luan, Danny
    Monge, Jorge
    Forsberg, Mark
    Bhatlapenumarthi, Vineel
    Balev, Metodi
    Patwari, Anannya
    Cheruvalath, Heloise
    Bhutani, Divaya
    Thanendrarajan, Sharmilan
    Dhakal, Binod
    Zangari, Maurizio
    Al Hadidi, Samer
    Cooper, Dennis L.
    Lentzsch, Suzanne
    van Rhee, Frits
    D'Souza, Anita
    Szabo, Aniko
    Schinke, Carolina
    Chakraborty, Rajshekhar
    BLOOD, 2023, 142
  • [29] Teclistamab in relapsed refractory multiple myeloma: multi-institutional real-world study
    Mohan, Meera
    Monge, Jorge
    Shah, Nishi
    Luan, Danny
    Forsberg, Mark
    Bhatlapenumarthi, Vineel
    Balev, Metodi
    Patwari, Anannya
    Cheruvalath, Heloise
    Bhutani, Divaya
    Thanendrarajan, Sharmilan
    Dhakal, Binod
    Zangari, Maurizio
    Al-Hadidi, Samer
    Cooper, Dennis
    Lentzsch, Suzanne
    van Rhee, Frits
    D'Souza, Anita
    Szabo, Aniko
    Schinke, Carolina
    Chakraborty, Rajshekhar
    BLOOD CANCER JOURNAL, 2024, 14 (01)
  • [30] Optec: A Phase 2 Study to Evaluate Outpatient Step-up Administration of Teclistamab in Patients with Relapsed/Refractory Multiple Myeloma (RRMM): Updated Results
    Rifkin, Robert
    Schade, Henning
    Simmons, Gary
    Yasenchak, Christopher
    Fowler, Jessica
    Lin, Thomas S.
    Kang, Lijuan
    Xu, Weiming
    BLOOD, 2024, 144 : 4753 - 4754
12345